OMCL logo

OMNICELL INC

OMCLNASDAQ
πŸ† #2033 by market capEarnings Oct 29 Β· PreUS Equity
$35.98β–Ό $0.76 (βˆ’2.07%)
Market closed Β· at close
πŸ””
Track OMCL
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 2.1%
7dβ–Ό 3.1%
14dβ–² 0.1%
30dβ–² 4.9%
ytdβ–Ό 20.6%
1yβ–² 21.8%
🏦Market Cap
$1.64B
Small Cap
πŸ“ˆRevenue Growth (YoY)
8.4%
Slowing
πŸ“ŠGross Margin
44.8%
Healthy
πŸ’΅FCF Margin
10.0%
Moderate
βš–οΈP/S Ratio
1.4x
Cheap
Otter Score
80
Strong

Trading Snapshot

Day Range
$35.51 – $37.31
52-Week Range
$29.09 – $55.00
Volume (shares)
75,998
Avg Volume (shares)
β€”
Shares Outstanding
45.6M
Next Earnings
2026-10-29

Fundamentals Snapshot

Annual Revenue
$1.18B
Last Q Revenue
$312M
P/E Ratio
43.1
P/S Ratio
1.4x
EPS (TTM)
$0.85
Dividend Yield
β€”
Dilution (1yr)
βˆ’2.8%
OMCL logo

OMNICELL INC

OMCL
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$1.2Bβ–² +6.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
42.9%β–² +1.3% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$12Mβ–² +3361.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$87Mβ–Ό βˆ’42.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
45.0Mβ–Ό βˆ’2.8% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$8Mβ–² +$6M YoY
StockOtter Β· stockotter.space

About OMNICELL INC

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
80/100
Analyst data unavailable.

Latest News & Updates

News unavailable.